Just another Daily Blogs News weblog
|
Aveo Pharmaceutical shares drop in trading debut
The Associated Press NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million. … |
Aveo Pharmaceutical shares drop in trading debut – The Associated Press
|
Aveo Pharmaceutical shares drop in trading debut
The Associated Press NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million. … |
Aveo Pharmaceutical shares drop in trading debut – The Associated Press
|
Aveo Pharmaceutical shares drop in trading debut
The Associated Press NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million. … |
Aveo Pharmaceutical shares drop in trading debut – The Associated Press
|
Aveo Pharmaceutical shares drop in trading debut
The Associated Press NEW YORK — Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million. … |
Aveo Pharmaceutical shares drop in trading debut – The Associated Press
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results …
MarketWatch (press release) MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical … |
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results …
MarketWatch (press release) MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical … |
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results …
MarketWatch (press release) MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical … |
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results …
MarketWatch (press release) MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical … |
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)
|
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results …
MarketWatch (press release) MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK) is a pharmaceutical company focused on commercializing anti-infective products that fulfill unmet medical … |
MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results … – MarketWatch (press release)
|
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor …
MarketWatch (press release) Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for … |
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor … – MarketWatch (press release)
Get News Headline on the motion